Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis

A limited number of therapeutic strategies are currently available for patients with inflammatory bowel disease (IBD). In particular, the maintenance therapy after remission in Crohn's disease (CD) is not satisfactory and new approaches are needed. Interleukin-10 gene-deficient (IL-10(–/–)) mic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Matsuda, C, Ito, T, Song, J, Mizushima, T, Tamagawa, H, Kai, Y, Hamanaka, Y, Inoue, M, Nishida, T, Matsuda, H, Sawa, Y
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2007
Gaiak:
Animal Studies
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1868878/
https://ncbi.nlm.nih.gov/pubmed/17437423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2007.03345.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak